ProFund Advisors »

Candel Therapeutics shares owned by ProFund Advisors

Quarter-by-quarter ownership of Candel Therapeutics (CADL) shares owned by ProFund Advisors from 13F filings

Historical chart of ProFund Advisors investment in Candel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Candel Therapeutics held by ProFund Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Candel Therapeutics by ProFund Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $295k 29k 10.30

More positions owned by ProFund Advisors

NVIDIA Corporation (NVDA)
Micron Technology (MU)
Broadcom (AVGO)
Apple (AAPL)
Advanced Micro Devices (AMD)
Microsoft Corporation (MSFT)
Intel Corporation (INTC)
Amazon (AMZN)
Applied Materials (AMAT)
Lam Research Corp Com New (LRCX)
Alphabet Cap Stk Cl A (GOOGL)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Kla Corp Com New (KLAC)

View all positions for ProFund Advisors

Top funds holding Candel Therapeutics

FMR
Rtw Investments
BlackRock
Acorn Capital Advisors
Portolan Capital Management
Saturn V Capital Management
Vanguard Capital Management
Geode Capital Management
Millennium Management
State Street Corporation
Halter Ferguson Financial
Northern Trust
Kennedy Capital Management
Vanguard Portfolio Management
Vanguard Fiduciary Trust

View all funds holding Candel Therapeutics